In the past twenty years, we have focused our efforts on the study of
kinin receptors involved in contraction or relaxation of vascular smoo
th muscle. Initial studies on rabbit vessels led to the discovery of t
wo kinin receptors, B-1 and B-2, mediating contraction of the rabbit a
orta (B-1) and the rabbit jugular vein (B-2). Studies on dog vessels c
ontributed to the identification of B-2 receptors in arterial endothel
ium promoting the release of NO and the relaxation of arterial smooth
muscles; further studies on dog renal vessels led to the demonstration
of B-2 receptors in endothelia and in the smooth muscle, mediating re
laxation through NO (endothelia) and prostanoids (smooth muscle). B-1
receptors that relax renal arterial smooth muscle through the release
of prostanoids were also identified. In other vessels, B-2 receptors m
ay also mediate smooth muscle contraction. Recent studies in human ves
sels (umbilical vein) have confirmed the existence of contractile B-1
and B-2 receptors in venous smooth muscles. B-1 and B-2 receptors have
been cloned; molecular biology has provided the reference data for co
mparison with findings of classical pharmacology and binding assays. S
imilarities and differences in B-1 and B-2 receptors between human and
animal tissues demonstrate the heterogeneity (related to species) of
kinin B-2 and B-1 receptors and confirm the findings of early classica
l pharmacological experiments.